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ABSTRACT 
 
Luminescent mesoporous europium or terbium doped hydroxyapatite (Eu/Tb: HAp) 
was successfully prepared through a simple one-step co-precipitation method using block 
copolymer pluronic 123. The phase, morphology, composition and luminescent property of 
Eu/Tb: HAp powders were characterized by X-ray diffraction, scanning electron microscopy 
(SEM), dynamic light scattering (DLS), fluorescence spectrophotometry and energy 
dispersive X-ray spectroscopy (EDX). XRD analysis reveals the nanocrystalline nature of 
HAP with crystallite size 22 nm. SEM images indicate the formation of ultrafine particles 
with uniform spherical morphology. In Eu/Tb: HAP the maximum intensities were achieved 
at 588 and 544 nm respectively with corresponding excitations at 400 and 340 nm. The 
stability of Eu/Tb: HAp, investigated by measuring the hydrodynamic size against time 
shows that there is almost no change of hydrodynamic size even after several days. This 
observation implies that such stable nanosystems can be used as luminescent drug carriers 
which can circulate in the blood stream for a long period minimizing the rapid clearance of 
particles by macrophages  
 
Keywords: Tb: Eu doped hydroxyapatite, Co-precipitation, Luminescence, Pluronic 123, 
Drug carrier1.  
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Introduction 
Development of nano drug-carrier has great importance due to many advantages over 
conventional forms of dosage, such as enhanced bioavailability, greater efficiency, lower 
toxicity, controlled release, and so on. 1–7Up to now, a large variety of nanosystems have 
been successfully employed as a means of sustained/controlled drug delivery, such as silica 
particles, 8 gold, 9carbon nanotubes, 10magnetic nanoparticles, 11 xerogels, 12 hydrogels.13 
However the major concerns for development of drug delivery Nano systems is their toxicity 
and biodegradability 14, 15. Among different storage/release systems, calcium phosphate 
including hydroxyapatite (HAP) materials has gained enhanced interest with particular 
attention as drug storage and release hosts for biomedical applications due to their unique 
properties such as porosity, high specific surface area, non-toxicity, biocompatibility and well 
modifiability surface. Hydroxyapatite (Ca10(PO4)6(OH)2),  the main mineral component of 
bones and teeth, is native to the human body. Combination of fluorescent properties onto 
HAP may enable the development of new multifunctional Nano composite for both 
therapeutic as well asbio imaging applications. 
Most fluorescent materials used in general are organic dyes and/or CdSe/ZnS 
quantum dots (QDs). However the photo bleaching, quenching of dye molecules, toxicity of 
QDs limit their applications in biomedical field. Most recently, lanthanide doped inorganic 
nanomaterial’s serve as a suitable alternative of these traditional fluorescent materials due to 
their excellent luminescence properties, including large Stokes shifts, narrow line–width 
emission bands, high quantum yields, long lifetimes and superior photo stability. As 
luminescent property of these materials arises from electronic transitions of these ions, their 
optical properties are rarely affected by surface modification.Trivalent rare earth ions doped 
hydroxyapatites  have  been  found  to  exhibit  favourable  optical properties  for  use  in  
laser  hosts.16-19However to our knowledge, the preparation and application of luminescent 
HAP in drug delivery systems have been reported only rarely. The reason for this might be 
that HA has a complicated crystal structure (in comparison to common oxides, such as SiO2) 
and it is very difficult to obtain stable porous HAP through traditional methods.It is  well  
known  that  poly(ethylene  glycol)–poly(propylene glycol)–poly(ethylene   glycol)   (PEG–
PPG–PEG)   block   copolymer exhibits  peculiar  behaviours  in  aqueous  solution. Below 
the characteristic temperature the critical micellar temperature (CMT), both the PEG and 
PPG blocks are soluble in water, and the copolymer molecules remain in the form of unimers 
in solution. At the CMT the PPG blocks become insoluble and form spherical micelles, with 
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PPO blocks as the hydrophobic core and the hydrated PEG blocks as the shell. The 
behaviours of block copolymer in water between the CMT and the cloud point (CP) have 
been extensively used to template various mesoporous materials 20-24while its characteristics 
below CMT and at CP have often been used in cloud point extractions. 25, 26Actually the 
behavioursbelow CMT and at CP of triblock copolymer–Pluronic P123 (EO 20 PO 70 EO 
20), i.e. completely insoluble at CP and totally soluble below CMT, can be adjusted for the 
preparation of HAP. 
The Tb3+/Eu 3+ doped HAP is one of the important green/red-emitting phosphors, and 
because the Tb3+/Eu 3+ ion is an important luminescent activator ion, showing emission due to 
5D4 → 7FJ transitions (J = 6, 5, 4, 3, 2)/5D0 → 7FJ transitions (J = 4, 3, 2, 1, 0) in the green/red 
region. 27–29 It is worth noting that porous materials functionalized with photoluminescence 
(PL) also have potential applications in the fields of drug delivery and disease diagnosis and 
therapy. 30–37 This is because these controlled drug delivery systems not only have high pore 
volumes for the storage and delivery of drugs but also possess photoluminescence properties 
which can be tracked to evaluate the efficiency of the drug release. 38, 39 
With this knowledge, we study the controlled synthesis of luminescent HAP using 
Tb3+/Eu3+ as luminescent material. We used triblock copolymer pluronic P123 as template for 
the synthesis of porous Nano HAP (n-HAP). Results demonstrated that the effects of weight 
of copolymer have significant influence on hydrodynamic size and property of the obtained 
HAP. The synthesized porous luminescent HAP with high surface area can be used as a drug 
carrier and facilitates the controlled drug release of antibiotic cefradine. 
2. Objective 
Recently, much attention has been focused on fabrication of luminescent n-HAP for 
colloidal stability at physiological condition, high surface area for maximum drug loading, 
and biocompatibility. Therefore, synthesis of functionalized, highly water dispersible 
luminescent nanoparticles with high drug loading capacity by an easy method involving 
cheap and easily available starting materials is desirable. In this regard, our present 
investigation is addressed on the followings 
 
 Synthesis of Tb3+/Eu3+-doped HAP luminescent nanoparticle using pluronic P-123 
copolymer as template. 
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 Study the effect of copolymer weight used on hydrodynamic size and surface of n-
HAP 
 Characterization of the phase, surface, morphology, surface area overall 
hydrodynamic size and fluorescence properties using standard characterization 
techniques like X-ray diffraction technique, FTIR, Scanning electron microscope 
(SEM), BET, dynamic light scattering and fluorescence spectroscopy. 
 Loading and release behaviours of model antibiotic cefradine 
 
3. A Brief review of previous work 
Owing to the challenging task for synthesis of luminescent porous HAP as drug 
carrier, this review focuses on various current synthetic strategies used to produce 
luminescent HAP and their physiological and optical properties. The knowledge of this 
review offers us valuable insight and inspiration to synthesize an efficient luminescent nano 
drug carrier based on biocompatible HAP. 
Zhu et al reported a facile method a facile method for the fabrication of amorphous 
calcium phosphate (ACP) /polylactide-block-monomethoxy(polyethyleneglycol) hybrid 
nanoparticles and ACP porous nanospheres. 40 For luminescent property they performed Eu 
doping. Flurescence propery of the prepared sample was investigated and they found the most 
intense peak at 612 nm for 5 mol% Eu 3+ doping. Nano carrier is utilised for a slow and 
sustained ibuprofen drug release in simulated body fluid (SBF) 
 
Fig.1. Strategy for the preparation of ACP/PLA-mPEG hybrid nanoparticles and ACP porous 
nanospheres 40 
HAP nano- and microcrystals with multiform morphologies (separated nanowires, 
nanorods, microspheres, microflowers, and microsheets) have been successfully synthesized 
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by Lin and co-worker using facile hydrothermal process.41 They claimed that bright blue 
emission under long wavelength UV light is due to the presence of CO 2•- radical impurities 
in the crystal lattice. Furthermore, they found that organic additive (trisodium citrate) and pH 
values have an impact on the morphologies and luminescence properties of the products. 
 
Fig.2. SEM images of HAP with different morphologies obtained at different pH values: (a, 
b) nanorods, pH) 7.0; (c, d) bur-like microspheres, pH ) 5.0; (e, f) microflowers, pH ) 4.5; and 
(g, h) microsheets, pH ) 4.0.41 
Tang et al reported a convenient strategy to obtain nano-HAP whose luminescence 
can be excited by visible lights. 42They reported that in their method only the surface calcium 
ions on the HAP nanoparticles are partially replaced by a small amount of Tb3+. It was also 
confirmed experimentally that the Tb-HAP nanoparticles can provide a steady luminescence 
The dimensions of the modified HAP are well controlled as their size distributions, 20 ( 5 nm, 
are relatively homogeneous. 
9 
 
 
Fig.3. Green emission of the internalized Tb-HAP particles in the cells under confocal 
microscopy 42 
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite (Eu:HAP)  
was  successfully prepared by Lin et al. through a simple one-step route using cationic 
surfactant as template. 43 They used the system as a drug delivery carrier to investigate the 
drug storage/release properties using ibuprofen (IBU) as a model drug. The   multifunctional   
HAP exhibits the typical mesoporous rod-like morphology with the particle size of 20–40 nm 
in width and 100–200 nm in length. 
 
Fig.4. Schematic representation of loading and release of IBU on Eu:HAp with the 
corresponding pellet photographs under the irradiation of 365 nm UV lamp 43 
Ma and co-worker reported a citric acid sol-gel combustion method to synthesize 
terbium doped calcium phosphate (Tb-doped CaP) nanocrystalline powders.44 The 4% Tb-
doped CaP Nano crystalline powders exhibit the strongest emission at 548 nm   (k excitation 
= 240 nm)   and   show   strong   green fluorescence under fluorescence microscopy. 
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Fig.5. SEM (a), TEM (b) and Fluorescence  microscopy (c) images  of  the  4%  Tb-doped  
CaP nanocrystalline powders44 
Eu3+/Gd3+-dual doped hydroxyapatite (HAP) nanorods were synthesized by Cui et al 
using hydrothermal method, they studied its photoluminescence (PL) properties, in vivo drug 
delivery  and imaging.45 The PL intensity  of  doped  HAP  nanorods  can  be  adjusted  by  
varying  Eu3+ and Gd3+ concentrations. They found that doping of Eu3+ and Gd3+ have 
influence on the crystal growth of HAP, leading to smaller size and narrower size distribution 
of Eu3+/Gd3+-HAP nanorods compared with undoped HAP nanorods.  
 
Fig. 6.  TEM micrographs of the samples prepared by a microwave-assisted hydrothermal 
method at 200 oC for 30 min: (a) undoped HAp nanorods; (b-d) Eu3+/Gd3+-HAP nanorods 
(Eu 3+ /Gd 3+ molar ratio = 1:1)45 
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4. Characterization 
The identification of crystalline phase of synthesized particles was performed by an 
Expert Pro Phillips X-ray diffractometer. The morphology and microstructure were analysed 
by scanning electron microscope (HITACHI COM-S-4200) operated at 300 kV. Mean 
particle diameters were measured after suitable dilution of the drug suspensions at 25.0 ± 0.5 
oC, by laser light scattering using a particle size analyser (Nano ZS 90, Malvern). 
Measurements were performed at 90 o angle in 0.01 M phosphate buffer varying pH 2 to 11. 
FTIR spectra of as prepared, samples were obtained   from a Thermo Nicolet Nexus FTIR 
model 870 spectrometer. Thermogravimetry analysis  was used to analyse the weight percent 
of the organic components included in samples.  
6. Results and Discussion 
The synthesis of Tb/Eu doped n-HAP was carried out by simple co-precipitation 
method using copolymer pluronic P 123 as template (scheme-1).To investigate the amount of 
copolymer effect on the formation of the Nano crystalsize, the synthesis was done at various 
weight values ranging from 0.5 to 2 g. Pluronic P123 could control the size distribution of the 
precipitated n-HAP. There was no significant difference between the n-HAP particles with 
andwithout the Tb/Eu treatment.  
 
Scheme-1: synthetic strategy for n-HAP-Eu3+/Tb3+ 
The composition and phase purity of the synthesised material is examined by XRD 
pattern. All the diffraction peaks of the synthesized nanoparticle can easily be indexed to pure 
hexagonal phase of HAP (JCPDS 09-0432). There is a large difference from each other in the 
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relative intensities of two samples in the XRD patterns (Fig. 7), indicating the possibility of 
perfect crystal growth on high temperature treatment. Moreover, as can be seen from the 
XRD patterns, high crystallinity can be realized at a relatively low treatment temperature (80 
°C) 
 
Fig.7. XRD pattern of n-HAP: Tb3+ (a) room temperature, (b) calcined sample 
 
An investigation on hydrodynamic size of n-HAP:Tb3+ with respect to the copolymer 
amount used was carried out through dynamic light scattering (Fig. 9 a) in PBS. It is found 
that average hydrodynamic size of the nanoparticle is 42 nm. With increase in amount of 
copolymer from 0.5g to 1 g there is a significant decrease in hydrodynamic size from 40 nm 
to 25 nm, however with further increase in copolymer amount there is increase in 
hydrodynamic size appreciable first, then no significant change is observed. The stability of 
n-HAP: Tb3+was investigated by measuring the hydrodynamic size against time (Fig. 9 b) 
shows that there is almost no change of hydrodynamic size even after several days. This 
observation implies that such stable nanosystems can be used as drug carrier which circulated 
in the blood stream for a long period minimizing the rapid clearance of particles by 
macrophages. 
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Fig.8. variation of hydrodynamic size with the amount of pluronic P123 (a) and time (b) 
The FTIR spectrum of n-HAP:Tb3+(Fig. 10) shows an intense broad splitted around 
1100-1000 cm-1 due to stretching vibration of phosphate group. In addition to this presence of 
bands at 872,600,and 569 cm-1 due to bending vibration of phosphate strengthen the HAP 
formation. The presence of additional peaks at 1418, 1600cm-1were due to CO32-,indicated 
that some carbonate group was incorporated into hydroxyapatite crystal structure replacing 
PO43- groups.46, 47Appearance of peaks around 2800-2900 cm-1 indicates incomplete removal 
of copolymer during synthesis of n-HAP. The broad band around 3450 cm−1 is due to the 
hydroxyl stretching vibration of the combined water of n-HAP.  
 
Fig.9. FTIR spectrum of n-HAP:Tb3+ 
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The surface properties of n-HAP:Tb3+ were further investigated by examining the 
surface charge over pH 2–10 by zeta potential measurement (Fig 11). It is observed that with 
increase in pH there is increase in zeta potential value. 
 
Fig.10. Variation of zeta potential of n-HAP with PH 
In order to further investigate the surface chemistry, n-HAP:Tb3+was studied using 
thermal analysis techniques of TG as shown in Fig.12. During heated to 800 ◦C, n-HAP 
showed three mass losses steps.The first mass loss occurs between 39 oC to 134 oC is due to 
the removal of moisture from surface of HAP nanoparticles. Continued heating resulted in 
subsequent slow (134 oC–500 oC) mass loss is due to decomposition of organic moiety 
present in pluronic P 123 along with lattice water. The gradual decrease in weight loss from 
600 to 800oC is due to the slow elimination of the carbonate group attached to the n-HAP 
nanoparticles. TG analysis shows that n-HAP is thermally stable up to 800 oC. 
 
Fig.11. Thermo gravimetric curve of n-HAP:Tb3+ 
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7. Conclusion 
We have successfully synthesised luminescent mesoporous n-HAP using a simple 
one-step co-precipitation method. This material exhibits high surface area, mesoporous, 
crystalline structure which can facilitate high drug encapsulation. As it shows high 
luminescent properties, it can be easily tracked and monitored in the drug release process. 
This system can be used for sustained and control release of antibiotic drug cefradine, which 
is under progress. 
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